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t seems self-evident that it would be 
useful to have a way of comparing 
alcohol policies between countries. 
A metric to compare countries would 
enable improvements or changes to 
be monitored; create benchmarks for 
comparative purposes; and potentially 
improve policy efﬁ  ciency and 
effectiveness. Indeed, the World Health 
Organization (WHO) in its alcohol 
policy report notes that “…it would 
be useful to develop a scientiﬁ  c way to 
measure and to evaluate overall policy 
comprehensiveness” [1].
But it seems that the endeavour is 
fraught. The multiplicity of problems—
conceptual, methodological, and 
political—lead some researchers and 
policy makers to conclude that the 
effort is not worth pursuing. For those 
brave or foolhardy enough to persist, 
including Brand and colleagues who 
now report their ﬁ  ndings in PLoS 
Medicine [2], there are a number 
of different ways of approaching a 
common metric. Inputs (such as 
government spending), outcomes 
(such as consumption or harm), 
and policy statements can all be 
measured and compared. Each of these 
different approaches has strengths 
and weaknesses, without a clear front-
runner.
Approaches to a Comparative 
Index
Government spending. The “inputs” 
approach is best characterised by 
government spending estimates. 
Measuring government expenditure is 
one clear way of comparing countries. 
Indeed, such comparative work has 
been reported in the literature [3–6]. 
Interestingly, this work has largely 
been conducted in the area of illicit 
drugs, not in the area of alcohol. 
Drug budgets are a “useful partial 
description of a nation’s drug policy” 
[5]. The national drug budget can be 
used to calculate what proportion of 
a country’s gross domestic product is 
spent on drug policy, enabling country 
comparisons. And the development 
of a shared methodology across 
research teams and countries means 
that this comparative work is now 
more sophisticated [6]. However, it 
has its limitations—for example there 
is no agreement as to what aspects 
of government spending should be 
included [6].
Cost-of-illness. The greatest criticism 
of the government spending approach 
is that it is merely measuring “inputs”, 
not the consequences of the policies. 
An alternate approach is that termed 
cost-of-illness, where the societal cost 
consequences of drug use (alcohol, 
tobacco, and/or illicit drugs) are 
calculated. Again there are a number 
of methodological stumbling blocks, 
but much work has been performed 
internationally to establish agreed-
upon methodological standards for 
the conduct of such studies. In 2003, 
the WHO published the “International 
Guidelines for Estimating the Costs 
of Substance Abuse” [7]. The cost-of-
illness approach has its critics. Moore 
and colleagues have identiﬁ  ed a 
number of improvements that could be 
made to cost-of-illness studies so that 
they could be more informative for 
policy [8].
Consumption and patterns of use. 
Consumption rates and patterns of 
use and associated harms for alcohol 
and illicit drugs is an obvious way of 
measuring and comparing countries. 
The WHO Global Status Report on 
Alcohol provides data on 189 countries 
in relation to per capita consumption 
of alcohol, drinking patterns, and 
health and social problems associated 
with alcohol [9]. Countries can be 
compared using these data—the 
presumption is that country policies in 
relation to alcohol drive its associated 
consumption and harms. It is not clear 
that one needs to go beyond data 
such as this to compare countries if 
one assumes that it is the outcomes of 
policies that are most important (rather 
than the existence of policies per se). 
And in this sense a consumption index 
represents a more direct metric than 
the government spending or cost-of-
illness approach.
Burden of disease. Another 
approach worth mentioning is the 
burden of disease. The assessment 
of the extent to which alcohol and 
other drugs contribute to overall 
burden of disease has become an 
important metric as measured 
by disability-adjusted life years or 
years of life lost. Clearly the burden 
of disease has a health focus, but 
nonetheless represents a single metric 
for evaluating a country’s alcohol 
responsiveness. The global burden of 
disease due to alcohol, illicit drugs, 
and tobacco has been estimated by 
global region [5]. Once again, there 
are limitations to this approach 
(see [5]). The burden of disease 
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approach is more sophisticated than 
consumption measures alone or cost-of-
illness studies, but still lacks an explicit 
connection with policy responses 
(although the connection is implied) 
and includes only the health aspects of 
alcohol and drug use. It ignores crime 
effects, social disruption, and economic 
aspects such as productivity losses.
Composite harm indices. For illicit 
drugs, there have been advances 
in developing composite indices of 
drug harms capable of providing 
comparative data either within country 
across time or between countries.
The 2005 United Nations World 
Drug Report describes the United 
Nation’s efforts to establish a global 
Illicit Drug Index for comparing the 
scale of the problem and monitoring 
strategic outcomes between countries 
across the world [10]. The aim is 
to establish a “single, standard and 
comparable measure of a country’s 
overall drug problem” [10]. The index 
measures the extent of the problem 
(not responses, nor socio-economic 
impacts). It has three components: 
production, trafﬁ  cking, and abuse. The 
components are combined to produce 
a single per capita ﬁ  gure for each 
country.
The Australian Federal Police have 
been working to produce a drug harm 
index that represents the dollar value 
of harm that would have ensued had 
seized drugs reached the community 
[11]. The index includes consumption 
estimates and social cost attributable 
to particular drugs, and then derives 
an estimate of an economic cost per 
kilogram of drug.
In the United Kingdom, the Home 
Ofﬁ  ce has developed a drug harm 
index to monitor changes in drug 
harm over time [12]. This index 
combines a number of indicators into 
one composite measure. Indicators 
include health consequences 
(morbidity, mortality), drug-related 
crime, community perceptions, and 
drug nuisance (19 harms in total). 
It incorporates social or economic 
cost through the weighting of the 
different harms by economic burden. 
To be useful for comparisons between 
countries, the index would need 
to be calculated for each country. 
As the authors note, the UK harm 
index is “purely a measure of realised 
outcomes”—it does not address 
the cost-effectiveness of one policy 
response over another.
Generalised cost-effectiveness 
analysis. For an index to include an 
effectiveness component, it needs 
to consider the cost-effectiveness of 
various policy options. The Generalised 
Cost-Effectiveness Analysis goes 
some way towards a comparative 
measure [13]. The approach enables 
cost-effective interventions to be 
identiﬁ  ed in the context of a country’s 
current consumption and existing 
interventions. Such an approach 
is helpful because it provides a 
sophisticated analysis of the mix of 
government interventions that are 
likely to produce the greatest efﬁ  ciency 
in terms of costs and beneﬁ  ts. The 
extent to which this approach can 
be applied to develop comparisons 
between countries is unknown. And 
like all the other measures, it has some 
signiﬁ  cant limitations.
None of the above indices, however, 
actually measure policy interventions 
per se. This is why the study in PLoS 
Medicine, which creates a new measure 
called the Alcohol Policy Index, is 
unique [2].
Another Comparative Index—
The Alcohol Policy Index
The Alcohol Policy Index is a different 
metric for comparing countries—it is 
not cost driven nor does it measure 
consequences as with the above 
measures. It could technically be 
described as an “input” model—i.e., 
it measures what countries say they 
do, not what outcomes their policies 
produce.
As Brand et al. describe, the Alcohol 
Policy Index rates countries on the 
extent to which they have implemented 
alcohol policies. The scores incorporate 
a weighting that reﬂ  ects the degree 
of evidence of effectiveness for each 
alcohol policy. Having established 
the scores for a number of countries, 
the authors then examine the degree 
of concordance between the country 
score and the country’s consumption 
levels (as reported in [9]). The authors 
ﬁ  nd a strong relationship between 
“policy strength” and per capita alcohol 
consumption. They have approached 
the exercise with appropriate statistical 
care.
The index is built around what 
was known (and published) in 2003 
regarding evidence for effectiveness. 
It excludes research since then on 
effective alcohol policies, and also 
excludes those strategies/policies that 
might work but lack an evidentiary 
base. The index could be updated 
with some of the cost-effectiveness 
work cited in the generalised cost-
effectiveness approach [13].
The Alcohol Policy Index has 
promise, but requires further 
development. For example, the validity 
of the index should be examined 
against a variety of other measures (not 
just per capita alcohol consumption, 
but alcohol harms). The major 
limitation of the Alcohol Policy Index is 
that it does not value the policy effects, 
nor link them to any of the above 
potential measures of policy impact. In 
addition, as Brand et al. note, it does 
not accommodate the implementation 
or enforcement of alcohol policies.
There have been other efforts to 
develop a scale that measures alcohol 
policies, and that is capable of being 
used to compare countries [14,15]. The 
Alcohol Policy Index and other scales 
of alcohol control policies provide only 
one way of enumerating the overall 
policy stance of a country. A remaining 
question is: which approach or set of 
measures will provide the best way 
forward for comparative analyses?
Where to From Here?
There are a set of generic problems 
associated with all of the approaches 
discussed above, including lack of 
available data; comparability problems 
between countries; lack of shared 
methodology between research 
groups; and the potential for large 
differences between regions or states 
within countries, making country-
level comparisons problematic. 
Country differences include important 
background variables such as 
cultural differences; social, political, 
and economic differences; and 
epidemiological and demographic 
differences. These differences 
may make any index simpliﬁ  ed 
and reductionistic to the point of 
uselessness. All of the potential indices 
only include what can be measured, 
not what would make the most sense 
conceptually.
If we assume, however, that some of 
the methodological and conceptual 
problems can be overcome and 
that such an index is indeed useful 
and worthy of scientiﬁ  c pursuit, the 
question then becomes: which index 
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provides the best possibilities?
I have considered seven different 
approaches here: government spending 
is advanced in terms of method 
and analysis, but provides a limited 
index; the cost-of-illness and burden 
of disease approaches calculate the 
extent of the problem; generalised 
cost-effectiveness analysis calculates 
the efﬁ  ciency of the solutions; and the 
harm index calculates costs, spending, 
and harms, but not effectiveness. The 
Alcohol Policy Index calculates policy 
implementation. Its ﬂ  aw is that it 
measures stated policy objectives and 
programs, not their implementation 
nor outcomes (costs, burden, or 
harms).
Perhaps the challenge from here is 
to develop a multidimensional index 
that can accommodate the dimensions 
of costs, consumption, harms, and 
cost-effective alcohol control policy 
responses.  
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